Brain Perfusion SPECT in Patients with PHACES Syndrome Under Propranolol Treatment

Abstract

Introduction Children with PHACES syndrome (PS) and visual impairment or stridor show a dramatic and immediate response to propranolol. However, this beta-blocking drug could be responsible for an eventually increased risk of ischemic stroke due to the underlying cerebral vascular disease. To more accurately understand the effects of propranolol on brain vascularization, we examined PS patients treated with this drug for airway or visual complications using brain perfusion SPECT (Single Photon Emission Computed Tomography). In the past, this examination has been shown to be useful in the management of patients with different neurovascular disorders.

Methods Clinical records and imaging studies were reviewed in 7 patients with a diagnosis of PS. All patients underwent magnetic resonance angiography (MRA), echocardiography, chest X-ray and ophthalmologic, neurological, and cardiologic assessments. They received 2–3 mg/kg/day propranolol in an attempt to treat stridor or avoid ophthalmologic occlusion. We performed SPECT after 3–6 months of treatment.

Results SPECT showed a normal uptake in the frontal and temporal regions despite vascular abnormalities found with MRA imaging. Significant improvements of symptoms and in the volume of the hemangioma were noted in all cases without signs of a reduction of brain blood perfusion.

Conclusions Propranolol treatment was safe in our patients who did not show signs of perfusion changes. The high sensitivity for detecting functional impairment makes brain perfusion SPECT useful in the diagnosis and follow-up of patients with PS considered at risk of neurovascular impairment. Accurate knowledge of its pathophysiological basis, together with the appropriate technique and careful interpretation of reporting, will enhance the clinical use of brain SPECT in those patients.

Keywords

hemangioma - propranolol - neurocutaneous syndromes - stroke - child - intracranial arteriovenous malformations/diagnosis

• References

• 1 Pascual-Castroviejo I. Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas. Neuroradiology 1978; 16: 82-84
• 2 Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132: 307-311
• 3 Metry D, Heyer G, Hess C , et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124: 1447-1456
• 4 Leboulanger N, Cox A, Garabedian EN , et al. Infantile haemangioma and beta-blockers in otolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis 2011; DOI: S1879-7296(11)00033-0. [pii]
• 5 Connelly EA, Viera M, Price C , et al. Segmental hemangioma of infancy complicated by life-threatening arterial bleed. Pediatr Dermatol 2009; 26: 469-472
• 6 Holmes WJ, Mishra A, Gorst C , et al. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg 2010; 125: 420-421
• 7 Leaute-Labreze C, Dumas de la Roque E, Hubiche T , et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651
• 8 Truong MT, Chang KW, Berk DR , et al. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010; 156: 335-338
• 9 Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol 2010; 38: 547-553
• 10 Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274
• 11 Mallick AA, O'Callaghan FJ. Risk factors and treatment outcomes of childhood stroke. Expert Rev Neurother 2010; 10: 1331-1346
• 12 Beslow LA, Jordan LC. Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations. Childs Nerv Syst 2010; 26: 1263-1273
• 13 Drolet BA, Dohil M, Golomb MR , et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006; 117: 959-964
• 14 Ganesan V, Prengler M, McShane MA , et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53: 167-173
• 15 Oza VS, Wang E, Berenstein A , et al. PHACES association: a neuroradiologic review of 17 patients. AJNR Am J Neuroradiol 2008; 29: 807-813
• 16 Heyer GL, Dowling MM, Licht DJ , et al. The cerebral vasculopathy of PHACES syndrome. Stroke 2008; 39: 308-316
• 17 Pascual-Castroviejo I, Pascual-Pascual SI, Viano J , et al. Major and minor arterial malformations in patients with cutaneous vascular abnormalities. J Child Neurol 2010; 25: 587-598
• 18 Pascual-Castroviejo I, Alvarez-Linera J, Coya J , et al. Pascual-Castroviejo type II syndrome (P-CIIS). Importance of the presence of persistent embryonic arteries. Childs Nerv Syst 2011; 27: 617-625
• 19 Kirkham FJ, Hogan AM. Risk factors for arterial ischemic stroke in childhood. CNS Spectr 2004; 9: 451-464
• 20 Fox CK, Fullerton HJ. Recent advances in childhood arterial ischemic stroke. Curr Atheroscler Rep 2010; 12: 217-224
• 21 Denoyelle F, Leboulanger N, Enjolras O , et al. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009; 73: 1168-1172
• 22 Prichard BN, Graham BR, Cruickshank JM. New approaches to the uses of beta blocking drugs in hypertension. J Hum Hypertens 2000; 14 (Suppl. 01) S63-S68
• 23 Kim BN, Kim JW, Kang H , et al. Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder. J Psychiatry Neurosci 2010; 35: 330-336
• 24 Sasaki M, Nakagawa E, Sugai K , et al. Brain perfusion SPECT and EEG findings in children with autism spectrum disorders and medically intractable epilepsy. Brain Dev 2010; 32: 776-782
• 25 Hayashi T, Shirane R, Fujimura M , et al. Postoperative neurological deterioration in pediatric MoyaMoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 2010; 6: 73-81
• 26 Bilgin O, Vollmar C, Peraud A , et al. Ictal SPECT in Sturge-Weber syndrome. Epilepsy Res 2008; 78: 240-243
• 27 Enjolras O, Soupre V, Picard A. Classification of superficial vascular anomalies. Presse Med 2010; 39: 457-464
• 28 Comi AM. Advances in Sturge-Weber syndrome. Curr Opin Neurol 2006; 19: 124-128